American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Business

Chick-fil-A announces shift from ‘no antibiotics’ in chicken pledge

by admin March 28, 2024
March 28, 2024
Chick-fil-A announces shift from ‘no antibiotics’ in chicken pledge

Chick-fil-A says it will no longer adhere to its pledge of serving antibiotic-free chicken.

In a statement released Monday, the fast-food company said that starting this spring it would serve chicken that was free only of antibiotics ‘important to human medicine,’ or those commonly used to treat people.

It said its poultry going forward may have been raised with animal antibiotics, though ‘only if the animal and those around it were to become sick.’ The chicken will continue to be free of artificial preservatives, steroids and added hormones, it said.

Chick-fil-A first announced its no-antibiotics pledge in 2014.

But amid an avian-flu outbreak that devastated poultry supplies nationwide, chicken farmers who’d previously sought to avoid antibiotics have been forced to turn to them. Last July, food processing giant Tyson announced it was ending its ‘no antibiotics ever’ pledge. Poultry producer Perdue Farms still has its pledge in place, while rival Pilgrim’s Pride says it uses some.

While world health officials have long raised concerns about the potential of any antibiotics in food to degrade the human body’s immunity to disease treatments, the Food and Drug Administration has said it is more concerned about the use of antibiotics commonly prescribed to humans than ones used to treat animal illnesses.

This post appeared first on NBC NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Customers from the East Coast to the Midwest could see costly impact from Baltimore bridge collapse
next post
Home price growth is back at pre-pandemic levels. Here’s what that means for buyers and sellers.

Related Posts

Taiwan probes 11 Chinese firms, alleges SMIC poached...

March 29, 2025

Supreme Court Justice Samuel Alito sold Bud Light...

May 23, 2024

Avoid the QQQ ETF, buy this Nasdaq 100...

February 26, 2025

HSBC share price forecast ahead of earnings: buy...

February 14, 2025

Meta executives eligible for 200% salary bonus under...

February 21, 2025

AMD’s post-earnings decline is a bit too unfair:...

February 5, 2025

Josh Brown questions Nike’s ability to turn around,...

May 30, 2025

Can Warren Buffett’s latest $338 million sale of...

October 3, 2024

Consumer staples outperform in 2025, but here’s why...

March 10, 2025

Is Elon Musk Nissan’s knight in shining armor?...

February 22, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Interview: Strategic location gives Brazil Potash cost advantage in domestic fertiliser market, says CEO Matt Simpson

      June 1, 2025
    • Canada’s Q1 GDP expands by 2.2%, driven by exports spike ahead of potential US tariffs

      June 1, 2025
    • President Trump to host farewell for Elon Musk as DOGE leader steps away

      June 1, 2025
    • UK’s digital banks face divergent fortunes: Starling stumbles, Monzo and Revolut soars

      June 1, 2025
    • Trump wants Apple to shift iPhone production from India to the US: here’s what it means

      May 18, 2025

    Categories

    • Business (3,094)
    • Investing (2,483)
    • Latest News (1,994)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved